Skip to main content
Top
Published in: Diabetes Therapy 1/2010

Open Access 01-08-2010 | Review

The OmniPod Insulin Management System: the latest innovation in insulin pump therapy

Author: Howard C. Zisser

Published in: Diabetes Therapy | Issue 1/2010

Login to get access

Abstract

This review of insulin pump therapy focuses on the OmniPod® Insulin Management System (Insulet Corp., Bedford, MA, USA). The OmniPod System is the first commercially available “patch pump.” It is a fully integrated wearable pump, controlled wirelessly through a handheld device containing a built-in blood glucose meter. This is an evaluation of the OmniPod System, with the aim of providing an educational tool for physicians who are considering recommending this product to their patients. The review includes a discussion of the traditional insulin pump configuration and its limitations, a detailed overview of the OmniPod System, references to clinical study data, planned product enhancements, its use as an insulin delivery system in the Juvenile Diabetes Research Foundation’s Artificial Pancreas Project, and its use to deliver additional compounds.
Literature
1.
go back to reference Zisser HC, Jovanovič L. OmniPod Insulin Management System: patient perceptions, preference, and glycemic control. Diabetes Care. 2006;29:2175. Letter.PubMedCrossRef Zisser HC, Jovanovič L. OmniPod Insulin Management System: patient perceptions, preference, and glycemic control. Diabetes Care. 2006;29:2175. Letter.PubMedCrossRef
2.
go back to reference Zisser HC. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions. Diabetes Care. 2008;31:238–239.PubMedCrossRef Zisser HC. Quantifying the impact of a short-interval interruption of insulin-pump infusion sets on glycemic excursions. Diabetes Care. 2008;31:238–239.PubMedCrossRef
3.
go back to reference Zisser HC, Bevier W, Dassau E, Jovanovič L. Siphon effects on continuous subcutaneous insulin infusion pump delivery performance. J Diabetes Sci Technnol. 2010;4:98–103. Zisser HC, Bevier W, Dassau E, Jovanovič L. Siphon effects on continuous subcutaneous insulin infusion pump delivery performance. J Diabetes Sci Technnol. 2010;4:98–103.
4.
go back to reference Kane MP, Abelseth JM, Davis K, Hogan E, Hamilton RA. Clinical experience with a tubingfree insulin pump system. Infusystems USA. 2009;6:25–27. Kane MP, Abelseth JM, Davis K, Hogan E, Hamilton RA. Clinical experience with a tubingfree insulin pump system. Infusystems USA. 2009;6:25–27.
5.
go back to reference Dilanni S, Garibotto J. An innovative application of shape memory alloy (SMA) technology yields a novel therapeutic approach to diabetes management. Insulet Corporation. 2006:12028–AW. Rev 2/04/09. Dilanni S, Garibotto J. An innovative application of shape memory alloy (SMA) technology yields a novel therapeutic approach to diabetes management. Insulet Corporation. 2006:12028–AW. Rev 2/04/09.
6.
go back to reference Sirotinin S, George C. Computer-aided learning in insulin pump training. J Diabetes Sci Technnol. 2010;4:1022–1026. Sirotinin S, George C. Computer-aided learning in insulin pump training. J Diabetes Sci Technnol. 2010;4:1022–1026.
7.
go back to reference Lane W, Weinrib SL, Rappaport JM, Przestrzelski T. A prospective trial of U-500 insulin delivered by OmniPod in patients with type 2 diabetes and severe insulin resistance. Endocr Pract. 2010. In press. Lane W, Weinrib SL, Rappaport JM, Przestrzelski T. A prospective trial of U-500 insulin delivered by OmniPod in patients with type 2 diabetes and severe insulin resistance. Endocr Pract. 2010. In press.
8.
go back to reference Dassau E, Palerm CC, Zisser H, Buckingham BA, Jovanovic L, Doyle FJ. In silico evaluation platform for artificial pancreatic beta-cell development—a dynamic simulator for closed-loop control with hardware-in-the-loop. Diabetes Technol Ther. 2009;11:187–194.PubMedCrossRef Dassau E, Palerm CC, Zisser H, Buckingham BA, Jovanovic L, Doyle FJ. In silico evaluation platform for artificial pancreatic beta-cell development—a dynamic simulator for closed-loop control with hardware-in-the-loop. Diabetes Technol Ther. 2009;11:187–194.PubMedCrossRef
9.
go back to reference Bruttomesso D, Farret A, Silvana C, et al. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J Diabetes Sci Technnol. 2009;3:1014–1021. Bruttomesso D, Farret A, Silvana C, et al. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier. J Diabetes Sci Technnol. 2009;3:1014–1021.
10.
go back to reference Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technnol. 2009;3:1031–1038. Clarke WL, Anderson S, Breton M, Patek S, Kashmer L, Kovatchev B. Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: the Virginia experience. J Diabetes Sci Technnol. 2009;3:1031–1038.
Metadata
Title
The OmniPod Insulin Management System: the latest innovation in insulin pump therapy
Author
Howard C. Zisser
Publication date
01-08-2010
Publisher
Springer Healthcare Communications
Published in
Diabetes Therapy / Issue 1/2010
Print ISSN: 1869-6953
Electronic ISSN: 1869-6961
DOI
https://doi.org/10.1007/s13300-010-0004-6

Other articles of this Issue 1/2010

Diabetes Therapy 1/2010 Go to the issue

Letter from the Editor

Letter from the Editor